EVGN, NGM

Evogene Ltd. (EVGN)

Price (as of September 24)

0.7801USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

DRTS

Alpha Tau Medical Ltd.

-0.13

ALLO

Allogene Therapeutics, Inc.

-0.09

ARGX

argenx SE

-0.08

ALLK

Allakos Inc.

-0.07

AMTI

Applied Molecular Transport Inc.

-0.06

APLS

Apellis Pharmaceuticals, Inc.

-0.06

ANTX

AN2 Therapeutics, Inc.

-0.06

ADVM

Adverum Biotechnologies, Inc.

-0.05

BCTX

BriaCell Therapeutics Corp.

-0.05

APM

Aptorum Group Limited

-0.05

Show more

Highest within Industry

Symbol Correlation

BNOX

Bionomics Limited

0.16

AURA

Aura Biosciences, Inc.

0.14

CCCC

C4 Therapeutics, Inc.

0.14

ACXP

Acurx Pharmaceuticals, Inc.

0.12

DSGN

Design Therapeutics, Inc.

0.11

BOLT

Bolt Biotherapeutics, Inc.

0.09

ABSI

Absci Corporation

0.09

ABOS

Acumen Pharmaceuticals, Inc.

0.08

ALXO

ALX Oncology Holdings Inc.

0.07

ABCL

AbCellera Biologics Inc.

0.07

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.